Horizon Therapeutics Public Limited Company is a company in the U.S. stock market and it is a holding in 128 U.S.-traded ETFs. HZNP has around 14.3M shares in the U.S. ETF market. The largest ETF holder of HZNP is the iShares Biotechnology ETF (IBB), with approximately 1.88M shares. Investors may also find of interest that the ETF with the largest allocation to HZNP stock is First Trust Nasdaq Pharmaceuticals ETF (FTXH), with a portfolio weight of 6.86%. On average, U.S. ETFs allocate 0.50% of HZNP to their portfolios.
Additionally, HZNP is a favorite stock for Vanilla and Multi-factor ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with HZNP as a holding is the iShares Morningstar Mid-Cap ETF (IMCB), with a return of 536.83%.